Left subclavian-carotid transposition in Ishimaru’s zone 2 thoracic endovascular aortic repair

Left subclavian-carotid transposition in Ishimaru’s zone 2 thoracic endovascular aortic repair - L-SCT prior to TEVAR

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00028204

Enrollment

Registered

2022-03-02

Start date

2021-02-03

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subclavian-Carotid-Transposition prior to TEVAR Spinal cord ischemia Stroke

Interventions

Group 1: Data of 21 consecutive patients, who underwent L-SCT prior to TEVAR with LSA coverage between July 2018 and September 2020 were evaluated. This study intended to assess L-SCT procedure-rela

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: patients, who underwent L-SCT prior to TEVAR with LSA-coverage

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
We evaluated all data regarding potential complications of the L-SCT procedure, such as 1) lymphatic fistula, 2) Horner's syndrome, 3) vocal cord paralysis and hoarseness, 4) left diaphragmatic palsy, 5) stroke, and 6) anastomotic occlusion with stroke, subclavian Steal syndrome and left arm ischemia or claudication.	—

Secondary

Measure	Time frame
The 30-day, 6-month, and most recent follow-up data were also analyzed. The development and recovery of perioperative L-SCT complications and neurological complications after TEVAR such as stroke, syncope, dizziness, paraparesis, or paraplegia were evaluated.	—

Countries

Germany

Contacts

Public ContactKay Schwenke

Universitätsklinikum MannheimAbteilung für Gefäßchirurgie

kay.schwenke@umm.de0621 383 2197

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026